<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Chin Med J (Engl)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Chin. Med. J</journal-id>
      <journal-id journal-id-type="publisher-id">CMJ</journal-id>
      <journal-title-group>
        <journal-title>Chinese Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0366-6999</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25963354</article-id>
      <article-id pub-id-type="pmc">4830313</article-id>
      <article-id pub-id-type="publisher-id">CMJ-128-1336</article-id>
      <article-id pub-id-type="doi">10.4103/0366-6999.156778</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Identification of a Novel Mutation in Solute Carrier Family 29, Member 3 in a Chinese Patient with H Syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Jia-Wei</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="author-notes" rid="fn1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Si</surname>
            <given-names>Nuo</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="author-notes" rid="fn1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Lian-Qing</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>Ti</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>Xue-Jun</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Xue</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Dong-Lai</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China</aff>
      <aff id="aff2"><label>2</label>Department of Medical Genetics, McKusick-Zhang Center for Genetic Medicine and State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China</aff>
      <aff id="aff3"><label>3</label>Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China</aff>
      <author-notes>
        <fn id="fn1">
          <p>Jia-Wei Liu and Nuo Si contributed equally to this work.</p>
        </fn>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Dong-Lai Ma, Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China E-Mail: <email xlink:href="mdonglai@sohu.com">mdonglai@sohu.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>20</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <volume>128</volume>
      <issue>10</issue>
      <fpage>1336</fpage>
      <lpage>1339</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Chinese Medical Journal</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="st1">
          <title>Background:</title>
          <p>H syndrome (OMIM 612391) is a recently described autosomal recessive genodermatosis characterized by indurated hyperpigmented and hypertrichotic skin, as well as other systemic manifestations. Most of the cases occurred in the Middle East areas or nearby countries such as Spain or India. The syndrome is caused by mutations in solute carrier family 29, member 3 (<italic>SLC29A3</italic>), the gene encoding equilibrative nucleoside transporter 3. The aim of this study was to identify pathogenic <italic>SLC29A3</italic> mutations in a Chinese patient clinically diagnosed with H syndrome.</p>
        </sec>
        <sec id="st2">
          <title>Methods:</title>
          <p>Peripheral blood samples were collected from the patient and his parents. Genomic DNA was isolated by the standard method. All six <italic>SLC29A3</italic> exons and their flanking intronic sequences were polymerase chain reaction (PCR)-amplified and the PCR products were subjected to direct sequencing.</p>
        </sec>
        <sec id="st3">
          <title>Results:</title>
          <p>The patient, an 18-year-old man born to a nonconsanguineous Chinese couple, had more extensive cutaneous lesions, involving both buttocks and knee. In his genomic DNA, we identified a novel homozygous insertion-deletion, c. 1269_1270delinsA, in <italic>SLC29A3</italic>. Both of his parents were carriers of the mutation.</p>
        </sec>
        <sec id="st4">
          <title>Conclusions:</title>
          <p>We have identified a pathogenic mutation in a Chinese patient with H syndrome.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>China</kwd>
        <kwd>H syndrome</kwd>
        <kwd>Novel Mutation</kwd>
        <kwd>The Solute Carrier Family 29, Member 3 Gene</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>I<sc>NTRODUCTION</sc></title>
      <p>H syndrome (OMIM 612391) is an autosomal recessive genodermatosis characterized by progressive cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hypogonadism, short stature, hearing loss, hallux valgus, camptodactyly and occasionally insulin-dependent diabetes mellitus (IDDM).[<xref rid="ref1" ref-type="bibr">1</xref>] The genetic analysis of patients with H syndrome revealed that homozygous mutations in the solute carrier family 29, member 3 (<italic>SLC29A3</italic>) gene on chromosome 10q22.1 are responsible for the phenotype.[<xref rid="ref2" ref-type="bibr">2</xref>] <italic>SLC29A3</italic> encodes the human equilibrative nucleoside transporter 3 (hENT3), which is highly conserved and contains 11 transmembrane domains (TMDs).[<xref rid="ref3" ref-type="bibr">3</xref>] The disease was first reported by Molho-Pessach <italic>et al</italic>. in 2008.[<xref rid="ref1" ref-type="bibr">1</xref>] So far, 85 patients have been reported in the literature with the clinical phenotypes characteristic of this syndrome and a total of 20 mutations have been identified in <italic>SLC29A3</italic>.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] The majority of patients are of Arab origin. There are also patients who from Spain, India and Japan. Here, we report on the clinical and molecular data of a new patient from China.</p>
    </sec>
    <sec sec-type="methods" id="sec1-2">
      <title>M<sc>ETHODS</sc></title>
      <p>Peripheral blood samples from the family members and 100 population-matched unrelated healthy control individuals were collected following informed consent and Institute Ethics Committee approval. Genomic DNA was isolated from peripheral blood leucocytes according to standard techniques.</p>
      <p>All 6 exons of <italic>SLC29A3</italic> were amplified by polymerase chain reaction (PCR) from the genomic DNA using Premix LA Taq (Takara Biotechnology Co., Dalian, China) and previously reported primers.[<xref rid="ref2" ref-type="bibr">2</xref>] The amplified PCR products were directly sequenced on an ABI Prism 3730&#xD7;l Automated Sequencer, using the ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems). For restriction analysis, a 269-bp fragment containing exon 6 of the human <italic>SLC29A3</italic> gene was PCR-amplified using the forward primer 5&#x2019;-CAAGGGTTCGGGCTCACTG-3&#x2019; and the reverse primer 5&#x2019;-TCTGCTCTCTGTCCCCAAGT-3&#x2019;. The PCR products were subsequently digested with the BanII restriction enzyme (Takara Biotechnology Co., Dalian, China) and analyzed on agarose gel.</p>
    </sec>
    <sec sec-type="results" id="sec1-3">
      <title>R<sc>ESULTS</sc></title>
      <sec id="sec2-1">
        <title>Clinical features</title>
        <p>We have reported the a Chinese patient with a clinical diagnosis of H syndrome.[<xref rid="ref8" ref-type="bibr">8</xref>] The patient was an 18-year-old male born to a nonconsanguineous Chinese couple. The clinical diagnosis was made according to his typical clinical phenotype, laboratory test abnormalities, and histological changing.</p>
        <p>The cutaneous lesion presented as symmetrical brown patches with tenderness, sclerodermoid induration and hypertrichosis on his thighs [<xref ref-type="fig" rid="F1">Figure 1a</xref>], knee [<xref ref-type="fig" rid="F1">Figure 1b</xref>], buttocks [<xref ref-type="fig" rid="F1">Figure 1c</xref>], back and lower abdomen. After puberty, he developed dysuria, gynecomastia, no spermatorrhea and erectile dysfunction. At the age of 18 years, he was 145 cm tall. He also had snaggletooth, enlarged inguinal lymph nodes, hearing loss, hepatosplenomegaly, heart anomaly, flat feet, bilateral fixed hammertoe deformity, and bilateral camptodactyly of the proximal interphalangeal joints of his second and third toes. His intelligence was of the average level.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Clinical presentation in H syndrome patient. (a) Extensive hyperpigmentation and hypertrichosis on his trunk, extremities; subcutaneous firm masses in the scrotal sac, obscuring the penis; prominent gynecomastia; (b and c) Indurated, hyperpigmented and hypertrichotic skin on the buttock and knee.</p>
          </caption>
          <graphic xlink:href="CMJ-128-1336-g001"/>
        </fig>
        <p>The patient had abnormal inflammatory indicators and abnormal hormonal levels: Elevated erythrocyte sedimentation rate (42 mm/h), C-reactive protein (34.6 mg/L) and CH50 (68.1 U/ml); significantly decreased level of testosterone (5.1 nmol/L) and elevated level of estradiol (270.56 pmol/L).</p>
        <p>Histopathology also showed a typical changing of H syndrome, such as widespread fibrosis and mononuclear infiltration. We did not find Psammoma body in the patient.</p>
        <p>Prednisone and short-acting androgen partially relieve the symptoms. After a follow-up of 5 years, the lesion became more severe than his first visit.</p>
      </sec>
      <sec id="sec2-2">
        <title>Identification of a novel mutation in solute carrier family 29, member 3</title>
        <p>Sequence analysis of all exons of <italic>SLC29A3</italic> in patient revealed a homozygous insertion-deletion (indel), c. 1269_1270delinsA, producing a frameshift and a premature termination codon (<italic>p.Leu423Serfs*28</italic>). This indel was predicted to disrupt the 10<sup>th</sup> and delete the 11<sup>th</sup> TMD of the <italic>SLC29A3</italic> protein. The father and mother were found to be heterozygous carriers of the indel [<xref ref-type="fig" rid="F2">Figure 2a</xref>]. The indel is not reported in the public dbSNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp/">http://www.ncbi.nlm.nih.gov/snp/</ext-link>) and was not detected in chromosomes from 100 ethnically matched control individuals, suggesting that c. 1269_1270delinsA (<italic>p.Leu423Serfs*28</italic>) in <italic>SLC29A3</italic> is the pathogenic mutation underlying H syndrome in the Chinese patient.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Identification of a novel mutation in the solute carrier family 29, member 3 (<italic>SLC29A3</italic>) gene. (a) Sequence analysis in patient and his parents; (b) Diagram of <italic>SLC29A3</italic>. The exons are represented by closed rectangles. 5&#x2019;UTR and 3&#x2019;UTR are represented by gray rectangles. Introns are represented by a straight line. Mutations are marked at the corresponding locations. The mutation identified in our patient is shown in red color.</p>
          </caption>
          <graphic xlink:href="CMJ-128-1336-g002"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="sec1-4">
      <title>D<sc>ISCUSSION</sc></title>
      <p>The skin lesion of H syndrome usually begins on lower limbs and generally extends to the whole body; however, knees and buttock were reported to be spared, which is considered to be a distinguishing feature of this disease.[<xref rid="ref9" ref-type="bibr">9</xref>] In our case, patient has the typical clinical and histological features. The diagnosis for H syndrome is made with certainty. The result of gene analysis further affirmed our diagnosis. However, it is noteworthy that in our case the cutaneous lesion is more extended, involving the areas such as buttocks and knees that were previously considered to be uninvolved.</p>
      <p>H syndrome is caused by mutations in the <italic>SLC29A3</italic> gene, which encodes the hENT3. hENT3 is a 475 amino acid protein with 11 TMDs. hENT3 belongs to a group of SLC transporters that are widely conserved in eukaryotes, the ENT or SLC29 family.[<xref rid="ref10" ref-type="bibr">10</xref>] The four members of the ENT mediate passive sodium-independent transport of nucleosides and display a broad tissue distribution such as brain compartments, spinal cord, eyes, lungs, kidneys, placenta, pancreas, stomach, and liver.[<xref rid="ref11" ref-type="bibr">11</xref>] Nucleoside transporters are essential for nucleotide synthesis by salvage pathways in cells that lack <italic>de novo</italic> synthetic pathways, such as histiocytes and monocytes.[<xref rid="ref10" ref-type="bibr">10</xref>] hENT3 is also expressed in the endothelium of blood and lymphatic vessels in normal human skin, as well as histiocytes that reside in the dermal sheath around the hair follicle.[<xref rid="ref12" ref-type="bibr">12</xref>] Disorder mutations could impair nucleoside transport, protein localization, and stability of hENT3.[<xref rid="ref11" ref-type="bibr">11</xref>] <italic>SLC29A3</italic> encodes a nucleoside transporter localized in lysosomes and is highly expressed in some white blood cells such as histiocytes and macrophages. Mice deficient in <italic>SLC29A3</italic> have significant lysosomal dysfunction in macrophages.[<xref rid="ref13" ref-type="bibr">13</xref>] It is possible that mutations in the <italic>SLC29A3</italic> gene may induce an abnormal proliferation of histiocytes and thus lead to the immune response, resulting in skin sclerosis and hypertrichosis.[<xref rid="ref11" ref-type="bibr">11</xref>] Germline mutations in <italic>SLC29A3</italic> have been reported in rare patients with a wide range of overlapping clinical features and inherited disorders including H syndrome, pigmented hypertrichosis with insulin-dependent diabetes (PHID), Faisalabad histiocytosis, sinus histiocytosis with massive lymphadenopathy, dysosteosclerosis (DSS) and monogenic autoinflammatory syndrome.[<xref rid="ref14" ref-type="bibr">14</xref>] H syndrome is characterized by skin hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism and low height. PHID is mainly characterized by presence of IDDM and lack of sensorineural hearing loss.[<xref rid="ref15" ref-type="bibr">15</xref>] Faisalabad histiocytosis presents with massive but painless lymphadenopathy. Lymph node histology reminiscent of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease), but the presence of short stature, joint contractures, and sensorineural deafness distinguishes this disorder.[<xref rid="ref16" ref-type="bibr">16</xref>] H syndrome is reported to have emperipolesis with sinus histiocytosis with massive lymphadenopathy.[<xref rid="ref17" ref-type="bibr">17</xref>] DSS is the form of osteopetrosis distinguished by the presence of skin findings such as red-violet macular atrophy, platyspondyly and metaphyseal osteosclerosis with relative radiolucency of widened diaphyses.[<xref rid="ref5" ref-type="bibr">5</xref>] The first four disorders were suggested to be grouped under the term histiocytosis&#x2013;lymphadenopathy plus syndrome (OMIM #602782). There is some clinical overlap between PHID and H syndrome, Faisalabad histiocytosis and sinus histiocytosis with massive lymphadenopathy, and in some families both conditions manifest.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref18" ref-type="bibr">18</xref>] In addition, mildly affected individuals have also been described,[<xref rid="ref19" ref-type="bibr">19</xref>] as well as a severe case presenting strikingly homologous with several syndromes.[<xref rid="ref20" ref-type="bibr">20</xref>] Twenty mutations have been identified so far in the <italic>SLC29A3</italic> gene in affected individuals [<xref ref-type="fig" rid="F2">Figure 2b</xref>]. However, the reasons for the pleiotropism and variability of <italic>SLC29A3</italic>-related diseases are not known. This indel (c. 1269_1270delinsA) changed leucine 423 to serine and was predicted to result in a frameshift and the generation of a stop codon at residue 451 of the protein, which will disrupt the 10<sup>th</sup> and delete 11<sup>th</sup> TMD of <italic>SLC29A3</italic>, leads to the dysfunction of the hENT3 and presents a series of clinical disorders. This mutation also affects the glycine at position 427, which is critical for nucleoside transport activity.[<xref rid="ref12" ref-type="bibr">12</xref>] This may explain the relatively extended cutaneous lesion in our case.</p>
      <p>In conclusion, the identification of the homozygous pathogenic indel confirmed the clinical diagnosis of H syndrome in our study. This is a Chinese mutation with H syndrome, extends the known geographical mutation distribution of the disease and expands the spectrum of <italic>SLC29A3</italic> mutations. The remarkable buttock and knee involvement of the patient add new features to the clinical spectrum. Knowledge of this disease is very limited, and precise pathogenesis of H syndrome has remained largely unknown. Future studies exploring the function of hENT3 will help in elucidating the pathophysiological basis for this disorder.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>A<sc>CKNOWLEDGMENTS</sc></title>
      <p>We acknowledge the family members involved in this study.</p>
    </ack>
    <fn-group>
      <fn fn-type="edited-by">
        <p><bold>Edited by:</bold> Li-Shao Guo</p>
      </fn>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> This work was supported by a grant from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (LRT1006 to Xue Zhang).</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>R<sc>EFERENCES</sc></title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molho-Pessach</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Agha</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Aamar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Glaser</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Doviner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hiller</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The H syndrome: A genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2008</year>
          <volume>59</volume>
          <fpage>79</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">18410979</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molho-Pessach</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lerer</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Abeliovich</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Agha</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Abu Libdeh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Broshtilova</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The H syndrome is caused by mutations in the nucleoside transporter hENT3</article-title>
          <source>Am J Hum Genet</source>
          <year>2008</year>
          <volume>83</volume>
          <fpage>529</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">18940313</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baldwin</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Cass</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>The equilibrative nucleoside transporter family, SLC29</article-title>
          <source>Pflugers Arch</source>
          <year>2004</year>
          <volume>447</volume>
          <fpage>735</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">12838422</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molho-Pessach</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ramot</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Camille</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Doviner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Babay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Luis</surname>
              <given-names>SJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>H syndrome: The first 79 patients</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2014</year>
          <volume>70</volume>
          <fpage>80</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">24172204</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campeau</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Sule</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Madan</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis</article-title>
          <source>Hum Mol Genet</source>
          <year>2012</year>
          <volume>21</volume>
          <fpage>4904</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">22875837</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Haggar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Salem</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wahba</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ahmad</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jonard</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Abdel-Hady</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome</article-title>
          <source>Pediatr Diabetes</source>
          <year>2014</year>
          <comment>doi: 101111/pedi12160</comment>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molho-Pessach</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mechoulam</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Siam</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Babay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ramot</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zlotogorski</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Ophthalmologic findings in H syndrome: A unique diagnostic clue</article-title>
          <source>Ophthalmic Genet</source>
          <year>2014</year>
          <comment>Epub ahead of print</comment>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The H syndrome (in Chinese)</article-title>
          <source>Chin J Dermatol</source>
          <year>2012</year>
          <volume>45</volume>
          <fpage>693</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farooq</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moustafa</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fujikawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Abbas</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kibbi</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: Expression studies of SLC29A3 (hENT3) in human skin</article-title>
          <source>Dermatology</source>
          <year>2012</year>
          <volume>224</volume>
          <fpage>277</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">22653152</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>NV</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Cangul</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gleeson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Straatman-Iwanowska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease</article-title>
          <source>PLoS Genet</source>
          <year>2010</year>
          <volume>6</volume>
          <fpage>e1000833</fpage>
          <pub-id pub-id-type="pmid">20140240</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baldwin</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Hyde</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Foppolo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>15880</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">15701636</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kang</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jun</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Bhutia</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Kannan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Unadkat</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Govindarajan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>28343</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">20595384</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Seshasayee</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis</article-title>
          <source>Science</source>
          <year>2012</year>
          <volume>335</volume>
          <fpage>89</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">22174130</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melki</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lambot</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jonard</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Couloigner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Quartier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Neven</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation in the SLC29A3 gene: A new cause of a monogenic, autoinflammatory condition</article-title>
          <source>Pediatrics</source>
          <year>2013</year>
          <volume>131</volume>
          <fpage>e1308</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">23530176</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cliffe</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Robben</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>de Jong</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>de Brouwer</surname>
              <given-names>AP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway</article-title>
          <source>Hum Mol Genet</source>
          <year>2009</year>
          <volume>18</volume>
          <fpage>2257</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">19336477</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossbach</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Dalence</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wynn</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tebbi</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Faisalabad histiocytosis mimics Rosai-Dorfman disease: Brothers with lymphadenopathy, intrauterine fractures, short stature, and sensorineural deafness</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>629</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">16155931</pub-id>
        </element-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Avitan-Hersh</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mandel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Indelman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bar-Joseph</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zlotogorski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bergman</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease</article-title>
          <source>Am J Dermatopathol</source>
          <year>2011</year>
          <volume>33</volume>
          <fpage>47</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">21178579</pub-id>
        </element-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Landeck</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>JQ</given-names>
            </name>
            <name>
              <surname>Lao</surname>
              <given-names>LM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Generalized pure cutaneous Rosai-Dorfman disease: A link between inflammation and cancer not associated with mitochondrial DNA and SLC29A3 gene mutation?</article-title>
          <source>Discov Med</source>
          <year>2013</year>
          <volume>16</volume>
          <fpage>193</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="pmid">24229736</pub-id>
        </element-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jonard</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Couloigner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pierrot</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Louha</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gherbi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Denoyelle</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: A very mild phenotype</article-title>
          <source>Eur J Med Genet</source>
          <year>2012</year>
          <volume>55</volume>
          <fpage>56</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">21888995</pub-id>
        </element-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Jesus</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Imane</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sen&#xE9;e</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guillausseau</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Balafrej</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis</article-title>
          <source>Diabetes Metab</source>
          <year>2013</year>
          <volume>39</volume>
          <fpage>281</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">23623699</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
